Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
This program assesses the laboratory’s ability to detect p16 overexpression in squamous cell carcinomas, mainly as a surrogate for HR-HPV detection in head and neck tumors.
- One 10‑core tissue microarray slide
Shipment A: April 12
Shipment B: November 15